Concepedia

Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole

James N. Ingle, Krishna R. Kalari, Aman U. Buzdar, Mark E. Robson, Matthew P. Goetz, Zeruesenay Desta, Poulami Barman, Tanda T. Dudenkov, Donald W. Northfelt, Edith A. Perez,

Steroids · 2014 · 44 citations · 9 references

DOIFull text

Open access

Concepts

References

9

Exemestane for Breast-Cancer Prevention in Postmenopausal Women

Paul E. Goss, James N. Ingle, José E. Alés‐Martínez et al. · New England Journal of Medicine · 2011 · 961 citations · Full text

, , +17

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

Jack Cuzick, Ivana Šestak, John Forbes et al. · The Lancet · 2013 · 585 citations · Full text

, , +14

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.

Aman U. Buzdar, W. Jonat, Anthony Howell et al. · PubMed · 1998 · 418 citations

, , +15

Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer

Jürgen Geisler, Nicholas King, Mitch Dowsett et al. · British Journal of Cancer · 1996 · 341 citations · Full text

, , +17

Arimidex�: A potent and selective fourth-generation aromatase inhibitor

Paul V. Plourde, Martin C. Dyroff, Michael Dukes · Breast Cancer Research and Treatment · 1994 · 257 citations

, , +9